Cisplatin-based adjuvant chemotherapy improves survival among patients with completely resected non-small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2004, 4(2): 94-96. DOI: 10.3969/j.issn.1671-5144.2004.02.009
|
Citation:
|
Cisplatin-based adjuvant chemotherapy improves survival among patients with completely resected non-small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2004, 4(2): 94-96. DOI: 10.3969/j.issn.1671-5144.2004.02.009
|
Cisplatin-based adjuvant chemotherapy improves survival among patients with completely resected non-small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2004, 4(2): 94-96. DOI: 10.3969/j.issn.1671-5144.2004.02.009
|
Citation:
|
Cisplatin-based adjuvant chemotherapy improves survival among patients with completely resected non-small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2004, 4(2): 94-96. DOI: 10.3969/j.issn.1671-5144.2004.02.009
|
DownLoad: